Delivery Order SPE2DB24D2018-SPE2DB25FWXB0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,175.76 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL formulations. The contract is firm fixed price with no set-aside designation and was competitively awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities, with a ceiling value of $1,026.67. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a discrete task under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,928.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and was awarded on August 14, 2025. This award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a $1,500.72 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin in 3 mL formulations, with an ultimate completion date of September 5, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on June 11, 2025, with a ceiling value of $1,917.75. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 12, 2025. This delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on August 5, 2025, with completion scheduled for August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities, with a contract value of $5,084.00 and completion deadline of September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,807.03 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL 3 mL insulin, with an ultimate completion date of August 6, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL pen format. This is a firm fixed-price contract with a ceiling value of $3,068.40 and an ultimate completion date of September 24, 2025. The contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWXB0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities, valued at $1,022.80 with a firm fixed price arrangement. The order, issued on September 26, 2025, has an ultimate completion date of September 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical federal medical procurement vendor, with an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/26/25 |